Patents by Inventor Mark Barry Abelson

Mark Barry Abelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11918573
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: March 5, 2024
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11617749
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: April 4, 2023
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20210290617
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 23, 2021
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
    Publication number: 20210177807
    Abstract: Methods of treating eyelid swelling in a subject comprising administering to the ocular surface of the subject an effective amount of glycerol and naphazoline. The glycerol can be present at a concentration of about 7.5% w/v and the naphazoline can be present at a concentration of about 0.01% to about 0.5% w/v. The compositions do not comprise an antihistamine.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 17, 2021
    Inventors: Matthew Jonathan CHAPIN, Mark Barry ABELSON, Keith Jeffrey LANE, George MINNO
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10987352
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: April 27, 2021
    Assignee: NICOX OPHTHALMICS, INC
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20200405711
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: September 11, 2020
    Publication date: December 31, 2020
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20200297719
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: April 3, 2020
    Publication date: September 24, 2020
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10675279
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: June 9, 2020
    Assignee: NICOX OPTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20180280383
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: June 6, 2018
    Publication date: October 4, 2018
    Inventors: Mark Barry ABELSON, Matthew J. CHAPIN, Paul GOMES, George MINNO, Jackie NICE
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9993471
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: June 12, 2018
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9750684
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: September 5, 2017
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20170182035
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
    Publication number: 20170079957
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconsgtrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Inventors: Matthew Jonathan Chapin, Mark Barry Abelson, Keith Jeffrey Lane, George Minno
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20160106666
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
    Publication number: 20140364475
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconsgtrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: April 10, 2014
    Publication date: December 11, 2014
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Matthew Jonathan CHAPIN, Mark Barry ABELSON, Keith Jeffrey LANE, George MINNO
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 8829005
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: September 9, 2014
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Compositions for the Treatment and Prevention of Eyelid Swelling
    Publication number: 20140161903
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Matthew J. Chapin, Mark Barry Abelson, Keith Jeffrey Lane, Akimitsu Makino
  • Method for the treatment and prevention of eyelid swelling
    Patent number: 8685439
    Abstract: The invention features novel topical ophthalmic formulations comprising an osmotically active agent and a vasoconstrictor. Suitable osmotically active agents for use in the ophthalmic formulations of the invention include, without limitation, sodium chloride, dextrose, glycerine, sucrose, mannitol, and sorbitol; suitable vasoconstritors include, without limitation, naphazoline and oxymetazoline. Also provided are methods of using the ophthalmic formulations of the invention for the treatment and prevention of eyelid swelling by administering the ophthalmic formulations of the invention to the eye surface of a subject in need thereof.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: April 1, 2014
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Matthew Jonathan Chapin, Mark Barry Abelson, Keith Jeffrey Lane, Akimitsu Makino
  • Ophthalmic Formulations Of Cetirizine And Methods Of Use
    Publication number: 20140045803
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: October 2, 2013
    Publication date: February 13, 2014
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 8569273
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: October 29, 2013
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice